International law firm Proskauer announced today the arrival of Dr. Fangli Chen as a partner and vice chair of the Life Sciences Patent practice, and Daniel Klein as senior patent counsel, both resident in its Boston office.
An accomplished lawyer with deep scientific experience, Dr. Chen focuses primarily on patent and intellectual property transactional work, including the strategic development and prosecution of complex worldwide patent portfolios for companies in the biotech and pharmaceutical industries, universities and research institutions. She also has established strengths handling inter partes reviews (IPRs) at the Patent Office, licensing and advising as investment or acquisition counsel.
Dr. Chen’s background combines a Ph.D. degree in biology from the Massachusetts Institute of Technology, an M.S. in plant pathology from Oklahoma State University and a B.S. in genetics from Fudan University (Shanghai, China) with experience as a patent practice technology specialist at a law firm. She received her J.D. from Suffolk University Law School.
Mr. Klein counsels companies and academic institutions in the design and implementation of intellectual property strategies in the areas of chemistry and pharmaceuticals, assisting clients in global patent portfolio creation and management; freedom-to-operate studies; non-infringement, patentability and invalidity analyses; due diligence investigations in connection with acquisitions and licenses; and pharmaceutical product lifecycle management. He previously served as in-house counsel at Millennium Pharmaceuticals and Wyeth. He holds an M.S. in organic chemistry from the University of Wisconsin and a B.S. in chemistry from Bucknell University. He received his J.D. from Duke University School of Law.
Steven Bauer, co-chair of Proskauer’s Litigation Department and the Firm’s Patent Litigation Group, said, “Fangli brings her reputation as one of the top life sciences patent lawyers in Boston to our tier 1 national patent practice. She and her team will be an invaluable asset to our practice and our clients who will greatly benefit from her deep scientific knowledge and sophisticated business sense.”
Siegmund Gutman, chair of the Firm’s Life Sciences Patent Practice, added, “The arrival of Fangli and her team enables us to better serve our clients by expanding the depth and breadth of our practice, as well as its geographic footprint, and highlights our leadership in addressing the intellectual property needs of the life sciences industry.”
“Proskauer advises companies on their most complex and cutting-edge IP and patent needs,” said Dr. Chen. “I am excited about the opportunity to bring my knowledge and experience to support the growth of the Firm’s Life Science Patent Law practice.”
Dr. Chen and Mr. Klein join Proskauer from the Boston office of Choate Hall & Stewart. In addition to the arrivals of Dr. Chen and Mr. Klein, our Life Science Patent team will also include patent agent and technology specialist Dr. Meaghan Bychowski and others. Dr. Bychowski works with life sciences clients of all sizes in the preparation and prosecution of patent applications. She holds a Ph.D. in neuroscience from the University of Wisconsin-Madison and a B.A., summa cum laude, in biology from Augustana College.
Source: www.proskauer.com
